NVGCT

The aim of the Netherlands Society of Gene & Cell Therapy is to promote both fundamental and translational research on gene & cell therapies. By bringing together all stakeholders (i.e. researchers, patients, physicians, government and regulatory authorities) the society aims to contribute to the swift development of new therapies for life-threatening diseases, including inherited diseases as well as acquired diseases such as cancer and cardiovascular diseases.

To achieve this, the society actively promotes:

  • Exchange of information and expertise between the various stakeholders
  • Public awareness of the status and possibilities of gene & cell therapy by organizing public events, workshops and lectures
  • Educational & Research-oriented sessions for researchers in the gene & cell therapy field (e.g. organisation of Spring Symposium)

Calendar

News

Vacancy: Technician Vector Analytics and Production @ MeiraGTx

Company MeiraGTx Netherlands is an Amsterdam based biopharmaceutical company developing local gene therapy for different indications. The company specializes in the development of viral gene therapy vectors, in particular adeno-associated virus (AAV) based therapeutics. Several product candidates are in the discovery and development phase. In our programs, we collaborate with world leading scientists. Position MeiraGTx …

Eureka Cell-Based Technologies call Vlaanderen – Nederland

Werkt u als bedrijf of onderzoeksinstelling aan marktgerichte R&D-projecten met focus op het stimuleren van publiek-privaat onderzoek en innovatie binnen het thema Cell-Based Technologies (celgebaseerde technologieën)? Wilt u daarbij samenwerken met partners in Nederland en België? Dan is deze gezamenlijke call van Nederland en Vlaanderen mogelijk iets voor u. Meer informatie, zie de rvo website

Our Sponsors